Dr Giménez-Arnau is currently Associate Professor of Dermatology at the Universitat Autònoma and Pompeu Fabra of Barcelona and Consultant Physician in Dermatology and Venereology in the Department of Dermatology at the Hospital del Mar Research Institute. Section of Inmunoallergic Cutaneous Diseases. She received her degree in Medicine and Surgery in Universitat of Barcelona and completed her doctorate training (cum laude) at the Autonomous University of Barcelona. She is board certified in Dermatology and Venereology. Her main research interests include urticaria and eczema, as well as contact dermatitis and atopic dermatitis.

Dr Giménez-Arnau is author of at least 371international and 250 national scientific publications, including also textbooks on Contact Dermatitis, Atopic Dermatitis, Urticaria and Therapy in Dermatology.

She is member of at least 16 Scientific Associations including the European Society of Contact Dermatitis (secretary from 2007–2012), European Society for Dermatology Research, European Academy of Dermatology (Chair Contact Dermatitis Task Force), European Dermatology Forum, European Academy of Allergy and Clinical Immunology and American Academy of Dermatology, American Academy of Dermatology and American Society of Contact Dermatitis. Dr Giménez-Arnau has been an external expert for the Scientific Committee on Consumer Safety (SCCS) for hair dyes and cosmetics at the European Commission non-food Scientific Committee. She is Spanish representative for the Dermatology section of the Union Europeen d´Especialite Medicales (UEMS) and at the COST Action- Standerm on prevention of Occupational Skin Diseases.

Nevertheless, I prefer to be presented mainly as a clinician involved daily in patients’ care and in any educational activities that contribute to spreading the best knowledge of Dermatologic conditions, which are the basis of her clinical research.

Miguel O. Nogueira, MD, is a specialist in Dermatovenereology, currently working at the Centro Hospitalar Universitário de Santo António in Porto. Dr. Nogueira leads the department’s autoimmune diseases clinic and co-leads the hidradenitis suppurativa clinic. He is a member of the Unit for Multidisciplinary Research in Biomedicine (UMIB) and is a member of the teaching team of Dermatovenereology at the Instituto de Ciências Biomédicas Abel Salazar, University of Porto (ICBAS-UP). Since 2023, he has been a PhD student, focusing on his thesis titled “Epigenetics in Immune-Mediated Skin Diseases”.

Emmanuella Guenova is a Full Professor of Dermatology and the designated Chair of the University Institute and Clinic for Immunodermatology at Johannes Kepler University Linz, effective April 2025. As a clinician-scientist with a profound interest in skin biology and the pathogenic mechanisms underlying skin inflammation and cancer, Emmanuella’s research centers on the intricate interactions between innate and adaptive immune responses against “non-self” elements, including pathogens and cancer cells.

Originally from Sofia, she completed her medical degree and MD at Eberhard Karl University in Tübingen, Germany, followed by a PhD in Biochemistry at the Medical University of Sofia, Bulgaria. Her translational research has advanced understanding of type 2 cytokines in innate immunity, exploring their potential as immunomodulatory targets for treating inflammatory skin diseases and skin cancers. Emmanuella also investigates the cellular mechanisms underlying cutaneous lymphoproliferative disorders, particularly cutaneous T- cell lymphomas like mycosis fungoides and Sézary syndrome.

Between 2010 and 2012, Emmanuella served as a postdoctoral researcher at Harvard Medical School (Boston, USA), focusing on immune regulation in immunocompromised patients and utaneous lymphomas. From 2013 to 2019, she directed the clinical program for lymphoproliferative skin diseases and co-led the outpatient dermatology clinic at the University Hospital Zurich (USZ). Since 2019, she has been an Associate Professor at the University of Lausanne, where she directed the Diagnostic and Precision Dermatology Unit at the University Hospital of Lausanne’s Department of Dermatology until April 2025.

Her work has earned numerous international accolades, including an appointment as Profesora Honorífica at the Department of Medicine, Universidad Complutense de Madrid, Spain.

2017-2022: Residency in Dermatology and Venereology, Coimbra University Hospital, Coimbra, Portugal.
Since 2022 working as a Dermatologist in the Dermatovenereology Department of Coimbra University Hospital Centre, in Coimbra, Portugal. Responsible for the Multidisciplinary Consultation of Cutaneous Lymphomas and working in the Dermato-oncology team.

January/2024: Did the European Board Examination in Medical Tumour Therapy in Dermato-Oncology, certified by U.E.M.S (European Board of Dermatology and Venereology) and EADO (European Association of Dermato Oncology), in Berlin.

Participated in the Horizon Programme (2022 – until now), involving clinical rotations in different European Expert Centres and investigation in the field of Cutaneous Lymphomas.

PhD student in the University of Medicine of Coimbra, Portugal, with main interest in Cutaneous Lymphomas.

Author or co-author of more than 40 scientific articles, speaker at several national and international conferences. Reviewer of scientific journals.

Khaled EZZEDINE is a Professor of Dermatology, with a PhD degree in Epidemiology and biostatistics, and an habilitation to supervise research in epidemiology. He is also a researcher attached to the research unit INSERM U1153/INRA U1125 of the Paris 13 University. His major topics of interest are pigmentation disorders including vitiligo and disorders on ethnic skin in adults and children, skin aging and research of its determinants. His research topics include qualitative epidemiology and he has leaded the construction of several quality of life scales in Dermatology. He is currently leading VOICE, the CHORD and Cochrane Initiative For Outcomes in Vitiligo of C3 (Chord Cochrane Collaboration). He is the head of the Global Vitiligo Atlas (GLOVA) which has been launched in 2023 under the auspices of the ILDS.

Since 2015, he has been appointed Professor of Dermatology at Paris Est Créteil University and has joined the Dermatology Department at Henri Mondor Hospital.  He has authored over 350 articles in referenced journals including The Lancet, The Journal of the American Medical Association, and the New England Journal of Medicine. He has published the Lancet Seminar on vitiligo. In addition, he is a reviewer for several leading medical journals such as the Lancet, the British Journal of Dermatology, JAMA Dermatology, JAMA, Journal of the European Academy of Dermatology and Venereology, Journal of the American Academy of Dermatology, Journal of Investigative Dermatology among others and has been recently appointed as the Section Editor for Epidemiology and pigmentary disorders of the Journal of the European Academy of Dermatology and Venereology.

Prof. Thomas Bieber is professor of Dermatology and Allergy. He received his degrees in medicine (MD) and biology (PhD in immunology) from the University of Louis Pasteur in Strasbourg, France. He then earned a master’s degree in drug regulatory affairs (MDRA from the University of Bonn), achieving special expertise in preclinical and clinical drug development strategies, as well as in legal and market access aspects of drug development. He has special expertise in translational and precision medicine approaches for skin diseases.

From 1997 to 2023, he was chair at the Department of Dermatology and Allergy at the University of Bonn, Germany. Since 2024, he is guest Professor at the Department of Dermatology at the University Hospital of Zürich, Switzerland. From 2010 to 2017, he was chief editor of Allergy, the official journal of the European Academy of Allergy and
Clinical Immunology. He was project leader of the Christine Kühne–Center for Allergy Research and Education. He founded the non-profit biotech company Davos Biosciences under the umbrella of the international Kühne-Foundation. He is currently the scientific director of the medicine programs at the Medicine Campus in Davos, Switzerland. He is founder of Bieber Dermatology Consulting, a firm specialized in advising pharmaceutical companies and investors in drug development strategy for medicinal products in dermatology and allergy.

Prof. Bieber has authored or coauthored more than 650 original publications and review articles (>50,500 citations; h-index = 107), more than 100 book chapters and several books on AD and precision medicine. Highly cited researcher by Clarivate and top 10 cited researchers of the University of Bonn in 2023. He is a member of the German National Academy of Sciences Leopoldina.

Among the honors: the distinguished Heisenberg Fellowship from the German Research Council, the Karl-Hansen-Award from the German Society of Allergy, the Pharmacia International Research Award, and the Gold Medal of the Foundation for Allergy Research in Europe. He has been invited to many distinguished lectureships, such as the Robert Cooke Memorial Lectureship by the American Academy of Allergy, Asthma and Immunology (USA), the international Dohi Memorial Lecture from the Japanese Society for Dermatology, the Bruno Bloch Memorial Lectureship from the University of Zürich (Switzerland), the Karl Herxheimer Memorial Lectureship from the University of Frankfurt and the Otto Braun-Falco Memorial Lectureship from the University of Munich (Germany) and the Erich Fuchs award of the Germany Society of Allergy.

Dr. Sergio Vañó Galván is a dermatologist and hair surgeon expert in hair research, director of the Hair Disorders Unit of the Ramón y Cajal University Hospital and the Hair Disorders and Hair Transplant Unit of Pedro Jaén Group Clinic, in Madrid. He holds a PhD in Medicine and an Associate Professor of Dermatology at the University of Alcalá. He is the Secretary General of the Spanish Society of Dermatology (AEDV).

He is former President of the Spanish Hair Research Society (2019-2023). Dr. Vañó-Galván leads an active research group in the study of different forms of alopecia (#TricoHRC). Dr. Vañó-Galván has published more than 300 scientific articles in Pubmed (h-index of 32) and he is a regular guest speaker in international congresses of hair research.

He is the Secretary General of the European Hair Research Society and member of the American Hair Research Society. He is Director of the International Master's Degree in Hair Disorders and Hair Transplantation at the University of Alcalá.

Future President of the World Congress for Hair Research (Madrid, 2028) Dr. Vañó-Galván also works as a Section Editor in the Journal of the European Academy of Dermatology and is an active user of social networks (@SergioVanoG, more information at: https://sergiovano.com/en/index.html).

Dr. Curdin Conrad is Professor of Dermatology at Lausanne University Hospital in Switzerland. He received his MD training at the University of Zurich, where he also participated at the Postgraduate Course of Experimental Medicine and Biology. After his training in Dermatology, he was research fellow at MD Anderson Cancer Center in Houston, Texas.

Dr. Conrad has a strong interest – from basic science to translational research and the clinic – in inflammatory skin diseases, adaptive and innate immunity, and targeted immunotherapies. He has fundamentally contributed to today’s understanding of the pathogenesis of psoriasis and has received several scientific awards for his basic and translational research. Over the years, Dr Conrad has actively been involved in the teaching of evidence-based clinical and scientific dermatology and immunology.

He serves as an external scientific expert for several international societies and foundations. Dr. Conrad is vice president of the Swiss Society of Dermatology and Venereology, an elected councilor of the International Psoriasis Council (IPC) and, as Secretary-Treasurer, member of the executive committee of the European Society for Dermatological Research (ESDR). He sits on the Board of Directors of the International Societies for Investigative Dermatology (ISID).

Prof. Dr. med. Jörg Wenzel, Assistant Professor and Vice Chair. Department of Dermatology, University Hospital Bonn
Dermatopathologist and dermato-oncology and experimental dermatology with special interest in Immune response mechanisms in autoimmune and neoplastic skin diseases, particularly cutaneous lupus erythematosus, where he
has a patent on the use of JAKi.
Author and co-author of about 337 publications (Publons/Web of science) with a h-Index: 46

Head of Dermatology, Coimbra University Hospital; Invited Professor of Dermatology, Faculty of Medicine, University of Coimbra; Board Representative at EADV Executive Committee (European Academy of Dermatology and Venereology); Co-opted member of EADV Scientific Programming Committee; Chair of EECDRG (European Environment Contact Dermatitis Group); responsible for the GA 2 LEN Urticaria Center of Reference and Excellence (UCARE) and Angioedema center (ACARE) of Coimbra. PhD thesis: Mechanisms of non-immediate immune-mediated drug eruptions (2014); author/co-author of 25 book chapters, >250 papers in peer-reviewed journals and more than 200 invited lectures.

Tiago Torres is Professor of Dermatology at University of Porto and the Head of the Psoriasis and Atopic Dermatitis Unit of the Department of Dermatology of CHUP. Through the years has been principal investigator for several psoriasis and atopic dermatitis clinical trials.

Tiago Torres has been involved in the development of national guidelines for the treatment of psoriasis and atopic dermatitis, has received the “Juvenal Esteves” Prize from the Portuguese Society of Dermatology and Venerology (SPDV) with research projects in psoriasis and psoriatic arthritis in 2011, 2013, 2017 and 2018 and two research grants from SPDV with research projects in atopic dermatitis in 2018 and 2019 Currently, he serves as Associate Editor of Acta Médica Portuguesa and Drugs in Context, Co-editor of Portuguese Journal of Dermatology and Venerology and belongs to the editorial board of Drugs, Journal of International Medical Research and the Foundation René Touraine’s Book “Therapeutics In Dermatology”.

Tiago Torres has been a founding member of the Atopic Dermatitis Group of SPDV, is the president of the Portuguese Group of Psoriasis, and is an International Psoriasis Council (IPC), Skin Inflammation & Psoriasis International Network (SPIN), Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and International Eczema Coucil (IEC) member.

Tiago Torres has published more than 100 articles on psoriasis and atopic dermatitis and has been the editor of the Portuguese book “Psoriasis and Psoriatic Arthritis”. His main research topics in dermatology are immunodermatology, immunology and immunopharmacology of psoriasis and atopic dermatitis.

Dermatology and Venereology, Hospital CUF Descobertas
Principal Investigator in Multicentric Clinical Trials in immune-mediated skin diseases
Member of GRAPPA – Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
Member of GPP – Portuguese Psoriasis Group of the Portuguese Society of Dermatology and Venereology
Multidisciplinary Dermatology-Rheumatology Clinic in Hospital CUF Descobertas
Volunteer scientific advisor of ADERMAP – Portuguese Atopic Dermatiitis Association

Dermatologist at the Central Lisbon University Hospital Center, Santo António dos Capuchos Hospital
Main clinical areas developed in the Department:

– Atopic Dermatitis consultation, certified by the GA²LEN Atopic Dermatitis Centres of
Reference and Excellence – ADCARE
– Psoriasis consultation
– Trichology / Adnexal diseases clinic
– Dermatologic surgery

Affiliated Lecturer at NOVA Medical School
Postgraduate by Harvard Medical School, Portugal Clinical Scholars Research Training Program
Investigator in several atopic dermatitis and psoriasis trials
More than 30 peer-reviewed papers and 60 lectures in scientific meetings

Professor Brian Kirby is a Consultant Dermatologist at St Vincent’s University Hospital and a Full Clinical Professor at University College Dublin. He is Principal Investigator at the Charles Institute of Dermatology at University College Dublin. His clinical and research interests include psoriasis and hidradenitis suppurativa.
Professor Kirby is a member of the steering committee of British Association of Dermatologists Biologics and Immunomodulatory Register, a member of the International Psoriasis Council, a member of the Scientific committee of the European Hidradenitis Suppurativa Foundation and Chairman of the Clinical Advisory Group of Dermatology at the Royal College of Physicians of Ireland.
He has authored or co-authored more than 270 PubMed quoted publications, the majority of which are on psoriasis and hidradenitis suppurativa. Together with Professor David Burden he has co-authored the chapter on Psoriasis and Psoriatic Arthritis in the latest edition of the Rook textbook. He is an Associate Editor of the British Journal of Dermatology and Dermatology.